MeSH tree: C12.050.351.937
Renal tumor pathology has evolved considerably, expanding from two main types of renal malignant tumors to over 20 distinct types. Diagnostic criteria have advanced from purely morphological features to include histochemistry, ...
Jun 18, 2024
0
44
Stacy Hernandez was 23 when she was told she had uterine cancer. She couldn't believe it. Not only did she have cancer, but one that had an average diagnosis age of 60 years old.
Jun 14, 2024
0
48
Researchers at Children's Hospital of Philadelphia (CHOP) announced the discovery of a novel immune-based biomarker that could pave the way for potential lifesaving early detection of high-grade ovarian cancer (HGOC). The ...
Jun 14, 2024
0
66
Close to half of America's tap water contains PFAS, or perfluoroalkyl and polyfluoroalkyl substances. These "forever chemicals" are in thousands of products, from clothing and cosmetics to cleaning products, and are linked ...
Jun 12, 2024
0
82
For nearly two decades, how kidney cancer becomes resistant to rapalog drugs has baffled the scientific community. Now a study by researchers at UT Southwestern Medical Center's Kidney Cancer Program sheds light. Published ...
Jun 12, 2024
0
59
US pharmaceutical and cosmetics giant Johnson & Johnson has agreed to pay $700 million to settle allegations it misled customers about the safety of its talcum-based powder products, New York's attorney general announced ...
Jun 12, 2024
0
82
Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive.
Jun 4, 2024
0
59
Two early-phase clinical trials presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting by researchers from The University of Texas MD Anderson Cancer Center demonstrate promising responses and safety ...
Jun 3, 2024
0
27
Some women who experience menopause early—before age 40—have an increased risk of developing breast and ovarian cancer, according to research being presented at ENDO 2024, the Endocrine Society's annual meeting in Boston, ...
Jun 3, 2024
0
34
Early detection improves treatment outcomes for endometrial and ovarian cancers, yet far too often women are diagnosed in advanced stages of these diseases. Unlike many other cancers, there are no standard screenings for ...
May 30, 2024
0
46
